While we celebrate mothers this weekend, scientists at the Oklahoma Medical Research Foundation are working constantly to protect them.
The goal of the new white paper is to create a dramatic shift in how lupus clinical trials are conducted so effective treatments can stand a chance to succeed.
The SMILE trial will seek to identify individuals at high risk for developing lupus and treat them before they ever transition into the disease.
The deadline for the eight-week summer program is Feb. 1.
Morris Reichlin helped build OMRF into one of the world’s leading centers for lupus research and treatment.
These findings will help scientists understand how to better diagnose and treat the disease.